Interleukin‐10 and interleukin‐4 inhibit intracellular killing of <i>Leishmania infantum</i> and <i>Leishmania major</i> by human macrophages by decreasing nitric oxide generation

European Journal of Immunology - Tập 27 Số 4 - Trang 860-865 - 1997
Ioannis Vouldoukis1, Pierre‐André Bécherel2,1, V. Riveros‐Moreno3, Michel Arock2, Otamires Da Silva4, Patrice Debré2, Dominique Mazier1, M. Djavad Mossalayi2
1INSERM U318, Pitié‐Salpětriere Hospital, Paris, France
2Groupe d'Immuno-Hématologie Moléculaire, CNRS URA625, Pitié-Salpêtrière Hospital, Paris, France
3King's College London, Biomedical Sciences Division, London, GB
4Universidade Federal de Pernambuco, Recife, Brazil

Tóm tắt

AbstractThe host response to Leishmania infection is regulated by a specific pattern of local cytokine production. We investigated the effect of interleukin (IL)‐10 and IL‐4 on the leishmanicidal activity of human macrophages (Mϕ). As with L. major, intracellular killing of L. infantum by human Mϕ was obtained following ligation of surface CD23 or cell treatment with Interferon‐γ (IFN‐γ). This leishmanicidal activity required nitric oxide (NO) generation by activated Mϕ, and it was partially mimicked by cell treatment with chemical NO donors. Addition of recombinant human IL‐10 or IL‐4 to CD23 mAb or IFN‐γ decreased L. infantum and L. major killing by infected Mϕ. IL‐10 was more potent than IL‐4 in inhibiting the leishmanicidal activity of human Mϕ. Inhibition of Leishmania killing by IL‐4 and IL‐10 correlated with decreased NO generation from Mϕ, and was reversed when exogenous NO was added to cell cultures. Therefore, IL‐10 and IL‐4 down‐regulate leishmanicidal activity of human Mϕ, in part by inhibiting NO generation by these cells.

Từ khóa


Tài liệu tham khảo

10.1007/978-1-4613-1575-9_108

10.1146/annurev.iy.13.040195.001055

Liew F. Y., 1990, J. Immunol., 144, 4793

Green S. J., 1991, J. Leukoc. Biol., 50, 93, 10.1002/jlb.50.1.93

10.1084/jem.180.3.783

Wu J., 1993, J. Immunol., 151, 4325, 10.4049/jimmunol.151.8.4325

10.1073/pnas.92.17.7804

10.1093/intimm/6.7.931

10.1016/0167-5699(95)80080-8

10.1172/JCI116341

10.1016/S0923-2494(94)80037-5

10.1016/0952-7915(93)90031-M

Lehn M., 1989, J. Immunol., 143, 3020, 10.4049/jimmunol.143.9.3020

Tapia F. J., 1993, J. Biol. Res., 26, 239

Carvalho E. M., 1994, J. Immunol., 152, 5949, 10.4049/jimmunol.152.12.5949

10.1172/JCI116372

10.1172/JCI116878

10.1172/JCI116570

10.1111/j.1365-3024.1995.tb00962.x

10.1002/jlb.55.2.227

10.1016/0006-291X(92)91852-H

10.4049/jimmunol.148.6.1792

10.1016/0304-4017(94)90003-5

10.1002/j.1460-2075.1992.tb05531.x

Frommel D., 1988, Infect. Immun., 56, 843, 10.1128/iai.56.4.843-848.1988

10.1007/BF02634089

Kolb J. P., 1994, J. Biol. Chem., 269, 9811, 10.1016/S0021-9258(17)36955-7

10.1073/pnas.90.8.3442

10.1146/annurev.iy.11.040193.001121

10.1002/eji.1830260632

10.1002/eji.1830251042

10.1002/eji.1830240328

10.1006/expr.1996.0100

10.1126/science.271.5251.987

10.1006/expr.1996.0103

10.1016/0090-1229(90)90038-R